In the livers of the two kinds of T2D mice, GCN2iB treatment resulted in a significant decrease in PYGL protein expression and increases in GLUT2, GCK, and PDHB protein expression and AKT phosphorylation (Figure 3K). The gene discussed is SLC2A2; the disease is type 2 diabetes mellitus.